J&K Weather: As the Kashmir Valley sees another fresh spell of snowfall, the second in 15 days, flight services were severely impacted in the region due to dense fog. Airport authorities ...

Phase 1 data shows encouraging safety and niche efficacy. Click here to find out why I maintain a buy rating for SDGR stock.

Kymera Therapeutics, Inc. (NASDAQ:KYMR) just reported positive results from its phase 1 healthy volunteer study using KT-621. The purpose of this clinical candidate is to develop it as an oral ...

Mersana’s ongoing Phase 1 trial of Emi-Le is enrolling TNBC patients who have undergone one to four prior treatments, including at least one topoisomerase-1 inhibitor ADC.

“We are thrilled with the successful completion of the Phase 1 SAD study, which demonstrated the safety and tolerability of TIX100 in humans,” said Dr. Anath Shalev, Founder and Chief ...

NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta (γδ) T cell therapies for cancer and ...

WATERTOWN, Mass., June 02, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader ...

The successful completion of two NBD1 Phase 1 trials and being the first company to bring NBD1 compounds into the clinic are important milestones,” said Mike Cloonan, President and Chief ...

Dr. Mainolfi continued, "Across every measure, the KT-621 Phase 1 results were exceptional. We exceeded our 90% STAT6 degradation target even at single doses as low as 6.25 mg, which supports KT-621's ...

Mumbai: Ichnos Glenmark Innovation (IGI), a joint venture between Glenmark Pharmaceuticals and Ichnos Sciences, on Monday shared promising results from an ongoing phase-1 trial of ISB 2001 ...